Sporadic Hemiplegic Migraine
Overview
Authors
Affiliations
Sporadic hemiplegic migraine (SHM) is defined as migraine attacks associated with some degree of motor weakness/hemiparesis during the aura phase and where no first degree relative (parent, sibling or child) has identical attacks. The present review deals with recent scientific studies according to which: The SHM prevalence is estimated to be 0.005%; SHM patients have clinical symptoms identical to patients with familial hemiplegic migraine (FHM) and significantly different from patients with migraine with typical aura (typical MA); SHM affected had no increased risk of migraine without aura (MO), but a highly increased risk of typical MA compared to the general population; SHM patients only rarely have mutations in the FHM gene CACNA1A; SHM attacks in some cases can be treated with Verapamil. The reviewed data underlie the change in the International Classification of Headache Disorders 2nd edition where SHM became separated from migraine with typical aura or migraine with prolonged aura. All cases with motor weakness should be classified as either FHM or SHM.
Transient hemiplegia in a patient with migraine: A case of sporadic hemiplegic migraine.
Maita H, Kobayashi T, Akimoto T, Osawa H, Hanada H SAGE Open Med Case Rep. 2024; 12:2050313X241275386.
PMID: 39193233 PMC: 11348355. DOI: 10.1177/2050313X241275386.
Unusual Presentation of a Hemiplegic Migraine in a Seven-Year-Old Child: A Case Report.
Alebaji M, Ani M, Rozieh S, Al Shibli A Cureus. 2023; 15(3):e36726.
PMID: 37123759 PMC: 10131133. DOI: 10.7759/cureus.36726.
Investigation of Cav3.3 Dysfunction in Hemiplegic Migraine.
Maksemous N, Blayney C, Sutherland H, Smith R, Lea R, Tran K Front Mol Neurosci. 2022; 15:892820.
PMID: 35928792 PMC: 9345121. DOI: 10.3389/fnmol.2022.892820.
Moore M, Stuart J, Humphreys A, Pfaff J Clin Pract Cases Emerg Med. 2019; 3(3):194-198.
PMID: 31404351 PMC: 6682222. DOI: 10.5811/cpcem.2019.4.42186.
Migraine with prolonged aura: phenotype and treatment.
Viana M, Afridi S Naunyn Schmiedebergs Arch Pharmacol. 2017; 391(1):1-7.
PMID: 29143861 DOI: 10.1007/s00210-017-1438-4.